Elizabeth Howard

General Counsel, Arbutus Biopharma.

Companies

Arbutus BiopharmaChief Compliance Officer Feb 19, 2020 to Feb 3, 2023¹
Arbutus BiopharmaGeneral counsel Mar 17, 2016 to Mar 5, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Arbutus Biopharma ABUS86,024 shares³$368.6K at $4.29Feb 1, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 1, 2023Granted 69,700 shares of Arbutus Biopharma³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARArbutus Biopharma, Chief Compliance Officer
2
SEC EDGARArbutus Biopharma, General counsel
3
SEC EDGARArbutus Biopharma shares after the filing of Feb 1, 2023